TY - JOUR
T1 - Adolescent therapeutic community treatment
T2 - an Australian perspective
AU - Northam, Jaimie Chloe
AU - MAGOR-BLATCH, Lynne
PY - 2016
Y1 - 2016
N2 - Purpose: The purpose of this paper is to provide an overview of the adolescent therapeutic community (ATC) literature - drawing on studies primarily from the USA with consideration made to the Australian context. Design/methodology/approach: A review of the efficacy research for ATCs is considered, and the characteristics of Australians accessing ATC treatment are discussed in the context of developmental needs. Findings: Similarities are found in what precipitates and perpetuates adolescent substance use in the USA and Australia, and therefore, what appears to facilitate effective treatment utilising the therapeutic community model. Originality/value: The paper provides a valuable perspective for Australian services, and explores the application of the ATC model within the Australian treatment context.
AB - Purpose: The purpose of this paper is to provide an overview of the adolescent therapeutic community (ATC) literature - drawing on studies primarily from the USA with consideration made to the Australian context. Design/methodology/approach: A review of the efficacy research for ATCs is considered, and the characteristics of Australians accessing ATC treatment are discussed in the context of developmental needs. Findings: Similarities are found in what precipitates and perpetuates adolescent substance use in the USA and Australia, and therefore, what appears to facilitate effective treatment utilising the therapeutic community model. Originality/value: The paper provides a valuable perspective for Australian services, and explores the application of the ATC model within the Australian treatment context.
KW - Alcohol
KW - Children and young people
KW - Drugs
KW - Residential
KW - TC practice
KW - Therapeutic communities
UR - http://www.scopus.com/inward/record.url?scp=84996554933&partnerID=8YFLogxK
U2 - 10.1108/TC-01-2016-0002
DO - 10.1108/TC-01-2016-0002
M3 - Article
SN - 0964-1866
VL - 37
SP - 204
EP - 212
JO - Therapeutic Communities
JF - Therapeutic Communities
IS - 4
ER -
